Medscape June 12, 2023
By Brendan Pierson

(Reuters) – A mandate that U.S. health insurers cover preventive care like cancer screenings and HIV-preventing medication at no extra cost to patients could remain in place while the Biden administration appeals a court order striking it down, following a tentative agreement announced on Friday.

The agreement between the administration and conservative businesses and individuals that sued to challenge the mandate is not yet final, according to a filing with the 5th U.S. Circuit Court of Appeals.

The deal would preserve the mandate nationwide while appeals play out, but allow the employer challenging the mandate, Texas-based Braidwood Management, to stop covering pre-exposure prophylaxis (PrEP) against HIV and other preventive services without co-pays for its employees for now.

The company, which...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: ACA (Affordable Care Act), Congress / White House, Govt Agencies, HHS, Insurance, Patient / Consumer, Provider
Anti-Fraud Efforts Meet Real-World Test During ACA Enrollment Period
CMS reports strong start to 2025 marketplace open enrollment, builds on record-setting success
Millions of Americans Remain Uninsured or Underinsured Despite ACA Gains
As Trump Looms, Biden Forecasts Another Record Obamacare Year
Washington Power Has Shifted. Here's How the ACA May Shift, Too.

Share This Article